Conference Speakers

Isabel Lauren Jackson, PhD is the Founding Principal of True North BioPharm, LLC, a boutique life sciences consulting company deeply rooted within the medical countermeasure (MCM) ecosystem. True North BioPharm partners with agencies, organizations, pharmaceutical and biotech companies driving medical preparedness and response for 21st century global health security threats. Prior to founding True North, Dr. Jackson served as the Marlene and Stewart Greenebaum Associate Professor of Radiation Oncology and Director of the Division of Translational Radiation Sciences at the University of Maryland School of Medicine in Baltimore, Maryland. As Director, Dr. Jackson led the development and execution of strategic plans to consolidate, refine, and expand the Division’s core capabilities based on a broad understanding of the MCM ecosystem and biomedical contract-research space. As Principal Investigator on numerous government contracts and research grants awarded to the UMSOM, Dr. Jackson oversaw a multi-year, multimillion dollar (>$50 m) translational research portfolio focused on early to advanced stage development of therapeutic interventions to treat radiation-induced blood failure, multi-organ injury, and fibrosis. Dr. Jackson has published more than 60 manuscripts in peer-reviewed journals, co-authored five book chapters on normal tissue tolerance to radiation and MCM interventions, been and frequently speaks at national and international conferences and workshops. She has been interviewed on numerous podcasts including Bill Nye’s Science Rules as well as for news (e.g., CNN Business) and journal (e.g., The Lancet) articles. She currently serves on the American Board of Radiology Radiation and Cancer Biology Committee and as Councilor at Large for the Radiation Research Society.